EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Children With Lennox Gastaut Syndrome.

Status:
Not yet recruiting

Trial end date:
2023-07-01

Target enrollment:

Participant gender:

EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Children With Lennox Gastaut Syndrome. (LGS)

Phase 2

Epygenix